The Flavonoid Quercetin Reverses Pulmonary Hypertension in Rats-Reference-Cited by-同舟云学术

The Flavonoid Quercetin Reverses Pulmonary Hypertension in Rats

Published:2014-12-02 Issue:12 Volume:9 Page:e114492
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Morales-Cano Daniel,Menendez Carmen,Moreno Enrique,Moral-Sanz Javier,Barreira Bianca,Galindo Pilar,Pandolfi Rachele,Jimenez Rosario,Moreno Laura,Cogolludo Angel,Duarte Juan,Perez-Vizcaino Francisco

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference47 articles.

1. Updated clinical classification of pulmonary hypertension;G Simonneau;J Am Coll Cardiol,2009

2. Pathogenic mechanisms of pulmonary arterial hypertension;SY Chan;J Mol Cell Cardiol,2008

3. Molecular pathogenesis of pulmonary arterial hypertension;M Rabinovitch;J Clin Invest,2008

4. Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension;KB Lane;Nat Genet,2000

5. Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor;C Atkinson;Circulation,2002

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology and flavonoids: Current research and future perspectives on cardiovascular health;Journal of Functional Foods;2024-09

2. Comparative analysis of antiproliferative and vasodilator effects of drugs for pulmonary hypertension: Extensive in vitro study in rats and human;Vascular Pharmacology;2024-06

3. Quercetin regulates pulmonary vascular remodeling in pulmonary hypertension through TGF-β1-Smad2/3 pathway;2024-03-19

4. Anti-hypertension effect of Wuwei Jiangya decoction via ACE2/Ang1-7/MAS signaling pathway in SHR based on network degree-distribution analysis;Journal of Ethnopharmacology;2024-01

5. An optimized machine learning method for predicting wogonin therapy for the treatment of pulmonary hypertension;Computers in Biology and Medicine;2023-09